Please login to the form below

Not currently logged in
Email:
Password:

S&H wins Doctors' Choice Awards

Sudler & Hennessey has been named a winner of a 2010 Doctors' Choice Awards for its work involving the launch of Simcor

Sudler & Hennessey (S&H) has been named a winner of a 2010 Doctors' Choice Awards. The award recognised S&H's work in the cardiovascular area for the launch of Simcor (simvastati/niacin).

The Doctors' Choice Awards, an annual study developed by Association of Medical Media (AMM), researches physician attitudes toward product advertising. This is done through web-based surveys covering 325 advertisements in 21 specialities, from the 86 most widely-advertised products in the previous calendar year.

The study was conducted by Readex Research, and drew more than 4,600 responses. This is the seventh year AMM has conducted the Doctors' Choice research.

Rob Rogers, co-CEO for S&H in the Americas said: "We are extremely proud of our talented staff and the many effective campaigns developed at S&H each year, a focus on creative that works has led to increased client satisfaction. This award is particularly meaningful as it is judged by the audience that truly matters."

The advertisements were judged on their ability to communicate quickly and clearly; help with clinical decisions; prompt physicians to seek further information or re-examine treatment; add to information generated by company sales representatives; and underscore the value of the product prescribed.

12th October 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics